Status:
COMPLETED
ETOILE : A Feasibility Study in Pediatric Patient Education
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Leukemia, Lymphoblastic
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
Feasibility study of a therapeutic education program for the patient and his carers, intended for children suffering from acute lymphoblastic leukemia or having received an allograft of hematopoietic ...
Detailed Description
This is a pilot feasibility study, of the quasi-experimental before-after, non-randomized, mono-centric type. Feasibility is assessed on process criteria (adoption, reach implementation, satisfaction)...
Eligibility Criteria
Inclusion
- Criteria relating to the population studied: child between 0 and 18 years old, followed at Robert Debré hospital (Paris), by a doctor from the hematology and immunology department
- Of which the 2 holders of parental authority have been informed and have signed the consent
- Having 1 or 2 caregivers available to accompany him during FTE sessions
- 1 to 2 of their adult caregivers will be eligible for the ETOILE program and will be included in the study after their consent.
- Child with acute lymphoblastic leukemia, treated at Robert Debré Hospital (Paris), in the induction or consolidation phase
- Child going to receive or having received an allograft of hematopoietic stem cells at the Robert Debré hospital (Paris)
- Beneficiaries of a social security scheme or entitled to it,
Exclusion
- Child not mastering the French language,
- Child with physical or cognitive disability to participate in the program,
Key Trial Info
Start Date :
July 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04399863
Start Date
July 9 2020
End Date
April 30 2021
Last Update
October 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Debre Hospital
Paris, France, 75019